{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:58:58Z","timestamp":1780894738614,"version":"3.54.1"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Microcytic hypochromic anemia is commonly presumed to represent iron deficiency anemia (IDA) at initial presentation. However, failure to respond to iron supplementation and iron indices inconsistent with IDA should prompt early diagnostic reassessment. We report a 67-year-old woman with severe microcytic hypochromic anemia after ineffective iron therapy. Iron studies indicated iron loading with impaired iron utilization rather than iron deficiency. Bone marrow Perls staining revealed ring sideroblasts in 14% of erythroblasts. Further stratified evaluation supported an acquired ring sideroblast phenotype, but the etiology could not be conclusively established. The patient received multifactorial supportive management, including discontinuation of unnecessary iron supplementation, early transfusion support, erythropoietin during hospitalization, pyridoxine supplementation, infection treatment, and optimization of comorbidities. Hemoglobin gradually improved and remained stable during follow-up without further transfusion. This case underscores the importance of early reassessment in older patients with iron-refractory microcytic anemia and discordant iron indices. Bone marrow Perls staining is critical for identifying ring sideroblasts. Assessment including SF3B1 testing may aid etiologic stratification, but SF3B1 negativity alone is insufficient to exclude clonal myeloid disease.<\/jats:p>","DOI":"10.3389\/fmed.2026.1838995","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:23:49Z","timestamp":1780892629000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A diagnostic pitfall in iron-refractory microcytic hypochromic anemia with acquired ring sideroblasts initially treated as iron deficiency anemia\u2014a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoqi","family":"Liu","sequence":"first","affiliation":[{"name":"College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juning","family":"Ma","sequence":"additional","affiliation":[{"name":"Weifang Traditional Chinese Hospital","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anning","family":"Song","sequence":"additional","affiliation":[{"name":"College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yang","sequence":"additional","affiliation":[{"name":"College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Li","sequence":"additional","affiliation":[{"name":"Weifang Traditional Chinese Hospital","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"Weifang Traditional Chinese Hospital","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3324\/haematol.2011.044628","article-title":"Ring sideroblasts and sideroblastic anemias","volume":"96","author":"Cazzola","year":"2011","journal-title":"Haematologica"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1182\/blood-2018-08-815951","article-title":"The molecular genetics of sideroblastic anemia","volume":"133","author":"Ducamp","year":"2019","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/JBM.S232644","article-title":"Understanding sideroblastic anemia: an overview of genetics, epidemiology, pathophysiology and current therapeutic options","volume":"11","author":"Abu-Zeinah","year":"2020","journal-title":"J Blood Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3390\/genes13091562","article-title":"Causes and pathophysiology of acquired sideroblastic anemia","volume":"13","author":"Rodriguez-Sevilla","year":"2022","journal-title":"Genes"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2018.08.008","article-title":"Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia","volume":"133","author":"Fujiwara","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1626S","DOI":"10.3945\/ajcn.117.155937","article-title":"Assessment of iron status in settings of inflammation: challenges and potential approaches","volume":"106","author":"Suchdev","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2450\/BloodTransfus.967","article-title":"Inflammation and iron homeostasis \u2013 what do blood tests mean? Markers of iron status during inflammation","volume":"23","author":"Marchi","year":"2025","journal-title":"Blood Transfus"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"101337","DOI":"10.1016\/j.blre.2025.101337","article-title":"Old tests and new paradigms: how to interpret iron studies and related biomarkers for the diagnosis of iron deficiency in adults","volume":"74","author":"Kriel","year":"2025","journal-title":"Blood Rev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1182\/blood.2024025575","article-title":"Pyridoxine: beyond a cofactor of ALAS","volume":"144","author":"Fujiwara","year":"2024","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1021\/acs.biochem.4c00066","article-title":"Elucidating the role of human ALAS2 C-terminal mutations resulting in loss of function and disease","volume":"63","author":"Taylor","year":"2024","journal-title":"Biochemistry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxx031","article-title":"Hyperferritinemia and inflammation","volume":"29","author":"Kernan","year":"2017","journal-title":"Int Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41375-024-02157-2","article-title":"The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the d\u00fcsseldorf MDS registry and proposals for a merged classification","volume":"38","author":"Nachtkamp","year":"2024","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"100615","DOI":"10.1016\/j.modpat.2024.100615","article-title":"Contemporary approach to the diagnosis and classification of myelodysplastic neoplasms\/syndromes\u2014recommendations from the international consortium for myelodysplastic neoplasms\/syndromes (MDS [icMDS])","volume":"37","author":"Aakash","year":"2024","journal-title":"Mod Pathol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1172\/JCI118258","article-title":"Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts","volume":"96","author":"Cotter","year":"1995","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1182\/blood-2002-09-2804","article-title":"Late-onset X-linked sideroblastic anemia following hemodialysis","volume":"101","author":"Furuyama","year":"2003","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"7046013","DOI":"10.1155\/crh\/7046013","article-title":"Successful treatment of Anemia with ringed Sideroblasts induced by antidepressants through vitamin B6 supplementation and discontinuation of antidepressants","volume":"2025","author":"Nakao","year":"2025","journal-title":"Case Rep Hematol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1637065","DOI":"10.3389\/fpsyt.2025.1637065","article-title":"Drug-induced severe sideroblastic anemia following combined olanzapine and fluvoxamine therapy: a case report","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Psych"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1838995\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:23:50Z","timestamp":1780892630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1838995\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":17,"alternative-id":["10.3389\/fmed.2026.1838995"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1838995","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"article-number":"1838995"}}